ArticleBritish journal of haematology2020
The combination of ibrutinib and rituximab demonstrates activity in first-line follicular lymphoma.
Nathan H Fowler et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this papertrialcites it